Industry Overview - The artificial joint industry in China is experiencing growth due to the increasing number of joint disease patients driven by an aging population. The market size is projected to reach 15.9 billion yuan in 2024, with a year-on-year growth of 11.19% [1][13] - Advanced technologies such as 3D printing, biomaterials, and robotic-assisted surgeries are widely applied in the artificial joint field, enhancing surgical precision, safety, and patient outcomes [1][13] Industry Development History - The development of the artificial joint industry in China has gone through four stages: initial stage (before 1983), foundational stage (1983-1999), scale and planning stage (2000-2012), and innovation and internationalization stage (2012-present) [4][5][6] - Significant advancements in materials science and manufacturing processes have been made, with notable innovations such as 3D printing for customized prosthetics and improved wear resistance of materials [6] Market Size - The market for artificial joints is expected to grow significantly due to the rising demand for joint replacement surgeries among the elderly population, which is projected to reach 310 million people aged 60 and above by 2024 [11][13] - The import of artificial joints decreased by 20.76% in quantity and 26.01% in value in the first five months of 2025, while exports increased by 11.91% in quantity and 10.53% in value [15] Key Companies - Leading companies in the artificial joint market include Weigao Orthopedics, Chuangli Medical, and Aikang Medical, which have established significant market shares through innovation and competitive pricing [19][20][22] - Aikang Medical reported a revenue of 1.346 billion yuan in 2024, reflecting a year-on-year growth of 23.03% [20] Industry Trends - The industry is witnessing a shift from "import substitution" to "technological overtaking," with domestic companies increasing their market share and focusing on high-end product development [24] - Digitalization and personalized customization are reshaping the industry, with AI and 3D printing technologies enhancing surgical planning and execution [25][26] - Chinese companies are expanding globally, targeting emerging markets in Southeast Asia, the Middle East, and Latin America, while facing competition from international giants [27]